Here are a few of the most interesting CureVac statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
- Website: Official Website
- Year Founded: 2000
- Headquarters: Tubingen, Germany
- Founder(s): Ingmar Hoerr
- Current Chief Executive: Franz-Werner Haas
What is CureVac?
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases. Based on its proprietary technology, the Company has built a deep clinical pipeline across the areas of prophylactic vaccines, cancer therapies, antibody therapies, and the treatment of rare diseases. CureVac had its initial public offering on the New York Nasdaq in August 2020. It is headquartered in Tübingen, Germany, and employs more than 600 people at its sites in Tübingen, Frankfurt, and Boston, USA. (source)
CureVac Employee Count
Number of CureVac employees:
Last updated 3/14/20
Total amount of funding raised by CureVac:
Last updated 6/13/19